Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
polyethylene glycol (1 trial)
polyethylene glycol 3350 (colyte) (1 trial)
miconazole (monistat) (1 trial)
neomycin (1 trial)
nystatin (mycostatin) (1 trial)
oxytocin (syntocinon) (1 trial)
polymyxin b sulfate (poly-rx) (1 trial)
ceftriaxone (rocephin) (1 trial)
clindamycin (cleocin) (1 trial)
fluoroquinolone (1 trial)
linezolid (zyvox) (1 trial)
rifampin (1 trial)
sulfamethoxazole (gantanol) (1 trial)
trimethoprim (1 trial)
vancomycin (Vancocin) (1 trial)
insulin human (humulin) (1 trial)
telmisartan (micardis) (1 trial)
Digestive System Diseases (Phase 4)
Gastrointestinal Diseases (Phase 4)
Infections (Phase 2)
Prader-Willi Syndrome (Phase 3)
Syndrome (Phase 3)
Vaginitis (Phase 3)
Trials (6 total)
Trial APIs (17 total)